You have 9 free searches left this month | for more free features.

City

Guangzhou (2)

Bengbu (1)

Changchun (1)

Guilin (1)

Hangzhou (1)

Shanghai (1)

Wuhan (1)

Yueyang (1)

Condition

Breast Cancer (1)

Gastroenteric Tumor (1)

Non-small Cell Lung Cancer (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd. (3)

Collaborator

SystImmune Inc. (2)

Intervention

bl-m02d1 (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

bl-m02d1

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NSCLC Trial in Shanghai (BL-M02D1)

Not yet recruiting

Non-small Cell Lung Cancer

BL-M02D1

Shanghai, Shanghai, China

Shanghai Pulmonary Hospital

Jul 10, 2023

Gastroenteric Tumor Trial in Guangzhou (BL-M02D1)

Recruiting

Gastroenteric Tumor

BL-M02D1

Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center

Jul 31, 2022

Breast Cancer Trial in Guangzhou (BL-M02D1)

Recruiting

Breast Cancer

BL-M02D1

Bengbu, Anhui, China
+9 more

Jan 11, 2023